Bo Løfgren and Anders Sjørslev Schmidt, ESC 2019 – Cardioversion in Atrial Fibrillation
We spoke to Drs Bo Løfgren and Anders Sjørslev Schmidt (Randers Regional Hospital, Randers, Denmark and Aarhus University and Aarhus University Hospital, Aarhus, Denmark) about their study into the use of maximum-fixed energy shocks for cardioverting atrial fibrillation. They also discuss the differences between various techniques and how they think these results will affect clinical practice.
Speaker’s Disclosures: Bo Løfgren and Anders Sjørslev Schmidt have nothing to declare in relation to this video interview.
1. What was the background and rationale of your study into maximum-fixed energy shocks for cardioverting atrial fibrillation? (0:05)
2. What were the methods you used for the study? (0:28)
3. What were the results of the study? (0:51)
4. What were the key messages of your findings? (1:18)
5. Are there significant differences between techniques, such as using different waveforms, or between high-energy shocks and escalating shocks? (1:45)
6. How do you think your results may affect clinical practice? (2:35)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with the Arrhythmia Alliance (A-A) at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
Share this Video
Related Videos In Atrial Fibrillation
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Søren Zöga Diederichsen, EHRA 2023: NT-proBNP as a tool for atrial fibrillation screening, post hoc analysis of the LOOP study
Recently it has been shown that NT-proBNP may be a useful tool for finding people with an increased risk of atrial fibrillation and stroke. In this touchCARDIO interview, we speak with Dr Søren Zöga Diederichsen (Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark) to discuss the post hoc analysis of the LOOP study. The abstract entitled ‘Atrial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!